119 related articles for article (PubMed ID: 7505049)
1. Hepatocellular carcinoma in the very elderly: to treat or not to treat?
Arbaje YM; Carbone PP
Med Pediatr Oncol; 1994; 22(2):84-7. PubMed ID: 7505049
[TBL] [Abstract][Full Text] [Related]
2. Education and Imaging. Hepatobiliary and Pancreatic: Complete remission after hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma with decompensated cirrhosis.
Seo JH; Song MJ
J Gastroenterol Hepatol; 2016 Jan; 31(1):10. PubMed ID: 26177574
[No Abstract] [Full Text] [Related]
3. A new therapeutic assessment score for advanced hepatocellular carcinoma patients receiving hepatic arterial infusion chemotherapy.
Saeki I; Yamasaki T; Tanabe N; Iwamoto T; Matsumoto T; Urata Y; Hidaka I; Ishikawa T; Takami T; Yamamoto N; Uchida K; Terai S; Sakaida I
PLoS One; 2015; 10(5):e0126649. PubMed ID: 25992784
[TBL] [Abstract][Full Text] [Related]
4. Effects of sorafenib combined with low-dose interferon therapy for advanced hepatocellular carcinoma: a pilot study.
Itokawa N; Atsukawa M; Tsubota A; Okubo T; Arai T; Nakagawa A; Kondo C; Iwakiri K
Int J Clin Oncol; 2016 Aug; 21(4):676-683. PubMed ID: 26701173
[TBL] [Abstract][Full Text] [Related]
5. Factors predicting response and survival in 149 patients with unresectable hepatocellular carcinoma treated by combination cisplatin, interferon-alpha, doxorubicin and 5-fluorouracil chemotherapy.
Akçali Z; Akin E; Ozyilkan O
Cancer; 2002 Nov; 95(9):2038-9; author reply 2039. PubMed ID: 12404300
[No Abstract] [Full Text] [Related]
6. Combined therapy consisting of intraarterial cisplatin infusion and systemic interferon-alpha for hepatocellular carcinoma patients with major portal vein thrombosis or distant metastasis.
Chung YH; Song IH; Song BC; Lee GC; Koh MS; Yoon HK; Lee YS; Sung KB; Suh DJ
Cancer; 2000 May; 88(9):1986-91. PubMed ID: 10813709
[TBL] [Abstract][Full Text] [Related]
7. Combination chemotherapy in the treatment of hepatoblastoma.
Staines A; Cullen S; Guiney EJ; Fitzgerald RJ; Breatnach F
Pediatr Hematol Oncol; 1990; 7(2):205-7. PubMed ID: 1698434
[No Abstract] [Full Text] [Related]
8. A novel chemotherapy for advanced hepatocellular carcinoma with tumor thrombosis of the main trunk of the portal vein.
Ando E; Yamashita F; Tanaka M; Tanikawa K
Cancer; 1997 May; 79(10):1890-6. PubMed ID: 9149014
[TBL] [Abstract][Full Text] [Related]
9. Combined cis-platinum and alpha interferon therapy of advanced hepatocellular carcinoma.
Ji SK; Park NH; Choi HM; Kim YW; Lee SH; Lee KH; Ahn SY; Lee SU; Han BH; Park BC
Korean J Intern Med; 1996 Jan; 11(1):58-68. PubMed ID: 8882477
[TBL] [Abstract][Full Text] [Related]
10. A randomized phase III study of doxorubicin versus cisplatin/interferon alpha-2b/doxorubicin/fluorouracil (PIAF) combination chemotherapy for unresectable hepatocellular carcinoma.
Yeo W; Mok TS; Zee B; Leung TW; Lai PB; Lau WY; Koh J; Mo FK; Yu SC; Chan AT; Hui P; Ma B; Lam KC; Ho WM; Wong HT; Tang A; Johnson PJ
J Natl Cancer Inst; 2005 Oct; 97(20):1532-8. PubMed ID: 16234567
[TBL] [Abstract][Full Text] [Related]
11. Hepatic arterial infusion chemotherapy using high-dose 5-fluorouracil and cisplatin with or without interferon-alpha for the treatment of advanced hepatocellular carcinoma with portal vein tumor thrombosis.
Eun JR; Lee HJ; Moon HJ; Kim TN; Kim JW; Chang JC
Scand J Gastroenterol; 2009; 44(12):1477-86. PubMed ID: 19958061
[TBL] [Abstract][Full Text] [Related]
12. [The progress of hepatic arterial infusion chemotherapy for hepatocellular carcinoma].
Noda T; Nagano H; Wada H; Marubashi S; Miyamoto A; Takeda Y; Umeshita K; Dono K; Ohsuga K; Kim T; Tomoda K; Nakamura H; Monden M
Gan To Kagaku Ryoho; 2006 Sep; 33(9):1221-5. PubMed ID: 16969014
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of early response to hepatic arterial infusion chemotherapy in patients with advanced hepatocellular carcinoma using the combination of response evaluation criteria in solid tumors and tumor markers.
Miyaki D; Kawaoka T; Aikata H; Kan H; Fujino H; Fukuhara T; Kobayashi T; Naeshiro N; Honda Y; Tsuge M; Hiramatsu A; Imamura M; Hyogo H; Kawakami Y; Yoshimatsu R; Yamagami T; Awai K; Chayama K
J Gastroenterol Hepatol; 2015 Apr; 30(4):726-32. PubMed ID: 25311578
[TBL] [Abstract][Full Text] [Related]
14. Fibrolamellar hepatocellular carcinoma in children and adolescents.
Katzenstein HM; Krailo MD; Malogolowkin MH; Ortega JA; Qu W; Douglass EC; Feusner JH; Reynolds M; Quinn JJ; Newman K; Finegold MJ; Haas JE; Sensel MG; Castleberry RP; Bowman LC
Cancer; 2003 Apr; 97(8):2006-12. PubMed ID: 12673731
[TBL] [Abstract][Full Text] [Related]
15. Hepatocellular Carcinoma in Children: Does Modified Platinum- and Doxorubicin-Based Chemotherapy Increase Tumor Resectability and Change Outcome? Lessons Learned From the SIOPEL 2 and 3 Studies.
Murawski M; Weeda VB; Maibach R; Morland B; Roebuck DJ; Zimmerman A; Casanova M; Perilongo G; Laithier V; Kebudi R; Scopinaro MJ; Shun A; Brichard B; de Camargo B; Childs M; Aronson DC; Czauderna P
J Clin Oncol; 2016 Apr; 34(10):1050-6. PubMed ID: 26811523
[TBL] [Abstract][Full Text] [Related]
16. Etoposide, cisplatin, epirubicin chemotherapy in the treatment of pediatric liver tumors.
Casanova M; Massimino M; Ferrari A; Spreafico F; Piva L; Coppa J; Luksch R; Cefalo G; Terenziani M; Polastri D; Bellani FF; Mazzaferro V
Pediatr Hematol Oncol; 2005; 22(3):189-98. PubMed ID: 16020101
[TBL] [Abstract][Full Text] [Related]
17. [Primary and secondary inoperable teratoid hepatoblastoma--multidisciplinary management].
Lackner H; Urban C; Sauer H; Lammer J; Pakisch B; Kaulfersch W; Gamillscheg A; Slavc I; Riccabona M; Klos I
Padiatr Padol; 1990; 25(5):299-312. PubMed ID: 1705020
[TBL] [Abstract][Full Text] [Related]
18. [Recent progress in chemotherapy for hepatocellular carcinoma].
Sakon M; Nagano H; Monden M
Nihon Naika Gakkai Zasshi; 2004 Aug; 93(8):1660-5. PubMed ID: 15384699
[No Abstract] [Full Text] [Related]
19. Combination chemotherapy for advanced hepatocellular carcinoma complicated by major portal vein thrombosis.
Kaneko S; Urabe T; Kobayashi K
Oncology; 2002; 62 Suppl 1():69-73. PubMed ID: 11868789
[TBL] [Abstract][Full Text] [Related]
20. "Silent" tyrosinemia presenting as hepatocellular carcinoma in a 10-year-old girl.
Castilloux J; Laberge AM; Martin SR; Lallier M; Marchand V
J Pediatr Gastroenterol Nutr; 2007 Mar; 44(3):375-7. PubMed ID: 17325560
[No Abstract] [Full Text] [Related]
[Next] [New Search]
